Ignite Creation Date:
2025-12-24 @ 11:00 PM
Ignite Modification Date:
2026-03-05 @ 7:58 PM
Study NCT ID:
NCT01157169
Status:
COMPLETED
Last Update Posted:
2020-01-18
First Post:
2010-07-02
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Buprenorphine 8 mg Sublingual Tablets Under Fasting Conditions
Sponsor:
Teva Pharmaceuticals USA
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
20-A63-AU
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
None
Old Organization:
TEVA Pharmaceuticals, USA